Performance Analysis of Workflow Model with Resource Constraints. - Ping Sun; Junli Wang 001; Xiangmei Li; Changjun Jiang (IMSCCS (1), 2006)

Computation on Attribute Importance of Classification Based on Cloud Model. - Hesong Li; Guangwei Zhang; Deyi Li; Xiangmei Li (CIMCA/IAWTIC/ISE, 2008)

Knowledge Discovery of Classification Based on Cloud Model and Genetic Algorithm. - Hesong Li; Guangwei Zhang; Deyi Li; Xiangmei Li (CSSE (4), 2008)

Vulnerability Analysis of Symbiosis Networks of Industrial Ecology Parks. - Yu Zeng; Renbin Xiao; Xiangmei Li (ITQM, 2013)

Impact of Rapid Urbanization on Vulnerability of Land System from Complex Networks View: A Methodological Approach. - Ying Wang 132; Xiangmei Li; Jiangfeng Li; Zhengdong Huang; Renbin Xiao (Complex., 2018)

The quality analysis of GNSS satellite positioning data. - Xiaoqing Zuo; Jinwei Bu; Xiangxin Li; Jun Chang; Xiangmei Li (Clust. Comput., 2019)

CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer. - Yuqi Sheng; Ying Jiang; Yang Yang 009; Xiangmei Li; Jiayue Qiu; Jiashuo Wu; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2021)

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy. - Xiangmei Li; Yalan He; Jiashuo Wu; Jiayue Qiu; Ji Li; Qian Wang; Ying Jiang; Junwei Han 003 (Briefings Bioinform., 2022)

Problem Characteristics and Dynamic Search Balance-Based Artificial Bee Colony for the Optimization of Two-Tiered WSN Lifetime with Relay Nodes Deployment. - Wenjie Yu; Xiangmei Li; Zhi Zeng; Miao Luo (Sensors, 2022)

DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network. - Jiashuo Wu; Xiangmei Li; Qian Wang; Junwei Han 003 (Bioinform., 2022)

iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. - Yuqi Sheng; Jiashuo Wu; Xiangmei Li; Jiayue Qiu; Ji Li; Qinyu Ge; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2023)

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19. - Yinchun Su; Jiashuo Wu; Xiangmei Li; Ji Li; Xilong Zhao; Bingyue Pan; Junling Huang; Qingfei Kong; Junwei Han 003 (Comput. Biol. Medicine, 2023)